Apogee Therapeutics, Inc. - COMMON STOCK (APGE)

CUSIP: 03770N101

Q3 2025 13F Holders as of 30 Sep 2025

Type / Class
Equity / COMMON STOCK
Shares outstanding
61,257,262
Total 13F shares
59,584,020
Share change
+1,692,036
Total reported value
$2,367,665,644
Put/Call ratio
41%
Price per share
$39.73
Number of holders
173
Value change
+$56,487,603
Number of buys
86
Number of sells
90

Security key

03770N101

Report period

Q3 2025

Institutions

173

Top holders

10

Top shareholders of APGE - Apogee Therapeutics, Inc. - COMMON STOCK (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
FMR LLC
13F 13D/G
Company
15%
from 13D/G
6,907,100
$299,975,353 30 Jun 2025
BlackRock, Inc.
13F 13D/G
Company
5.5%
from 13D/G
2,562,539
$111,291,045 30 Jun 2025
DRIEHAUS CAPITAL MANAGEMENT LLC
13F 13D/G
Company
4.7%
from 13D/G
2,310,755
$100,356,090 30 Jun 2025
Venrock Adviser, LLC
13F
Company
14%
8,493,321
$368,864,931 30 Jun 2025
13F
WELLINGTON MANAGEMENT GROUP LLP
13F
Company
6.2%
3,805,710
$165,281,985 30 Jun 2025
13F
RTW INVESTMENTS, LP
13F
Company
4.4%
2,712,097
$117,786,373 30 Jun 2025
13F
VANGUARD GROUP INC
13F
Company
3.4%
2,108,938
$91,591,178 30 Jun 2025
13F
Fairmount Funds Management LLC
13F
Company
3.3%
2,048,647
$88,972,739 30 Jun 2025
13F
BRAIDWELL LP
13F
Company
2.4%
1,478,512
$64,211,776 30 Jun 2025
13F
ALLIANCEBERNSTEIN L.P.
13F
Company
2.3%
1,388,149
$60,287,311 30 Jun 2025
13F
ADAGE CAPITAL PARTNERS GP, L.L.C.
13F
Company
2.1%
1,290,464
$56,044,852 30 Jun 2025
13F
STATE STREET CORP
13F
Company
2.1%
1,259,258
$54,689,575 30 Jun 2025
13F
Point72 Asset Management, L.P.
13F
Company
2%
1,230,377
$53,435,260 30 Jun 2025
13F
PERCEPTIVE ADVISORS LLC
13F
Company
1.9%
1,182,148
$51,340,688 30 Jun 2025
13F
JPMORGAN CHASE & CO
13F
Company
1.8%
1,125,570
$48,883,504 30 Jun 2025
13F
Paradigm Biocapital Advisors LP
13F
Company
1.6%
958,630
$41,633,301 30 Jun 2025
13F
Woodline Partners LP
13F
Company
1.4%
870,208
$37,793,133 30 Jun 2025
13F
FRANKLIN RESOURCES INC
13F
Company
1.4%
852,531
$37,025,423 30 Jun 2025
13F
MERCER GLOBAL ADVISORS INC /ADV
13F
Company
1.3%
820,376
$35,628,930 30 Jun 2025
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
1.3%
782,641
$33,994,283 30 Jun 2025
13F
PRICE T ROWE ASSOCIATES INC /MD/
13F
Company
1.2%
760,844
$33,045,000 30 Jun 2025
13F
Affinity Asset Advisors, LLC
13F
Company
1.1%
691,899
$30,049,174 30 Jun 2025
13F
GOLDMAN SACHS GROUP INC
13F
Company
1.1%
659,186
$28,628,448 30 Jun 2025
13F
Jefferies Financial Group Inc.
13F
Company
1%
642,357
$27,897,565 30 Jun 2025
13F
BARCLAYS PLC
13F
Company
0.99%
608,822
$26,441,139 30 Jun 2025
13F
Siren, L.L.C.
13F
Individual
0.97%
594,994
$25,840,589 30 Jun 2025
13F
JANUS HENDERSON GROUP PLC
13F
Company
0.83%
509,321
$22,119,942 30 Jun 2025
13F
BANK OF AMERICA CORP /DE/
13F
Company
0.83%
508,987
$22,105,306 30 Jun 2025
13F
CITADEL ADVISORS LLC
13F
Company
0.81%
495,659
$21,526,470 30 Jun 2025
13F
Polar Capital Holdings Plc
13F
Company
0.81%
495,000
$21,497,850 30 Jun 2025
13F
MORGAN STANLEY
13F
Company
0.77%
474,702
$20,616,337 30 Jun 2025
13F
Novo Holdings A/S
13F
Company
0.73%
449,392
$19,517,095 30 Jun 2025
13F
First Turn Management, LLC
13F
Company
0.51%
311,490
$13,528,011 30 Jun 2025
13F
FRONTIER CAPITAL MANAGEMENT CO LLC
13F
Company
0.5%
309,066
$13,422,736 30 Jun 2025
13F
Commodore Capital LP
13F
Company
0.47%
290,000
$12,594,700 30 Jun 2025
13F
JENNISON ASSOCIATES LLC
13F
Company
0.44%
270,366
$11,741,994 30 Jun 2025
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.43%
266,384
$11,569,057 30 Jun 2025
13F
NORTHERN TRUST CORP
13F
Company
0.43%
264,188
$11,473,685 30 Jun 2025
13F
VICTORY CAPITAL MANAGEMENT INC
13F
Company
0.42%
254,770
$11,064,661 30 Jun 2025
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
0.4%
245,133
$10,646,126 30 Jun 2025
13F
Ikarian Capital, LLC
13F
Company
0.38%
232,047
$10,077,802 30 Jun 2025
13F
Bank of New York Mellon Corp
13F
Company
0.33%
201,151
$8,735,981 30 Jun 2025
13F
TANG CAPITAL MANAGEMENT LLC
13F
Company
0.33%
200,000
$8,686,000 30 Jun 2025
13F
D. E. Shaw & Co., Inc.
13F
Company
0.32%
194,528
$8,448,351 30 Jun 2025
13F
Capital World Investors
13F
Company
0.32%
193,895
$8,420,860 30 Jun 2025
13F
Blackstone Inc.
13F
Company
0.29%
178,546
$7,754,253 30 Jun 2025
13F
BALYASNY ASSET MANAGEMENT L.P.
13F
Company
0.26%
158,635
$6,889,518 30 Jun 2025
13F
AMERIPRISE FINANCIAL INC
13F
Company
0.25%
156,108
$6,779,771 30 Jun 2025
13F
Granahan Investment Management, LLC
13F
Company
0.21%
131,138
$5,695,323 30 Jun 2025
13F
Universal- Beteiligungs- und Servicegesellschaft mbH
13F
Individual
0.21%
125,829
$5,464,753 30 Jun 2025
13F

Institutional Holders of Apogee Therapeutics, Inc. - COMMON STOCK (APGE) as of Q3 2025

As of 30 Sep 2025, Apogee Therapeutics, Inc. - COMMON STOCK (APGE) was held by 173 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 59,584,020 shares. The largest 10 holders included VR ADVISER, LLC, FMR LLC, WELLINGTON MANAGEMENT GROUP LLP, RTW INVESTMENTS, LP, BlackRock, Inc., VANGUARD GROUP INC, Driehaus Capital Management LLC, Fairmount Funds Management LLC, STATE STREET CORP, and Paradigm Biocapital Advisors LP. This page lists 173 institutional shareholders reporting positions in this security for the Q3 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q3 2025 vs Q2 2025 Across Filers

Q2 2025 holders
180
Q3 2025 holders
173
Holder diff
-7
Investor Q2 2025 Shares Q3 2025 Shares Share Diff Share Chg % Q2 2025 Value $ Q3 2025 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .